RIZATRIPTAN FLAS QUALIGEN 10 mg ORALLY DISINTEGRATING TABLETS

2. What you need to know before taking Rizatriptan Flas Qualigen

Do not take Rizatriptan Flas Qualigen

• if you are allergic to rizatriptan benzoate or any of the other ingredients of this medication (listed in section 6).
• if you have moderately severe, severe, or uncontrolled mild high blood pressure.
• if you have or have had heart problems, including heart attack or chest pain (angina) or have experienced signs related to heart disease.
• if you have severe liver or kidney problems.
• if you have had a stroke (CVA) or a transient ischemic attack (TIA).
• if you have problems with obstruction in your arteries (peripheral vascular disease).
• if you are taking monoamine oxidase inhibitors (MAOIs) such as moclobemide, phenelzine, tranylcypromine, or pargyline (medications for depression), or linezolid (an antibiotic), or if it has been less than two weeks since you stopped taking an MAOI.
• if you are currently taking ergotamine-like medications, such as ergotamine or dihydroergotamine for migraine, or methysergide for migraine prevention.
• if you are taking any other medication of the same class, such as sumatriptan, naratriptan, or zolmitriptan for migraine. (See also Other medications and Rizatriptan Flas Qualigenbelow).

If you are unsure whether any of the above applies to you, consult your doctor or pharmacist before taking Rizatriptan Flas Qualigen.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Rizatriptan Flas Qualigen if:

• you have any of the following risk factors for heart disease: high blood pressure, diabetes, smoking, or using nicotine substitutes, family history of heart disease, being a male over 40 years old or a postmenopausal woman.
• you have kidney or liver problems.
• you have a specific problem with the way your heart beats (left bundle branch block).
• you have or have had any allergies.
• your headache is associated with dizziness, difficulty walking, lack of coordination, or weakness in your leg and arm.
• you take herbal remedies containing St. John's Wort.
• you have had allergic reactions such as swelling of the face, lips, tongue, and/or throat that can cause difficulty breathing or swallowing (angioedema).
• you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram, and fluoxetine or serotonin and norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine and duloxetine for depression.
• you have had transient symptoms including pain and pressure in the chest.

If you take Rizatriptan Flas Qualigen too frequently, it may cause you to develop chronic headache. In such cases, you should contact your doctor, as you may need to stop taking Rizatriptan Flas Qualigen.

Tell your doctor or pharmacist about all your symptoms. Your doctor will decide if you have migraine. You should only take Rizatriptan Flas Qualigen for a migraine attack.

Rizatriptan Flas Qualigen should not be used to treat other types of headaches that may be caused by more serious conditions.

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medication. This includes herbal remedies and medications you normally take for migraine. This is because Rizatriptan Flas Qualigen may affect how some medications work, and other medications may also affect Rizatriptan Flas Qualigen.

Other medications and Rizatriptan Flas Qualigen

Do not take Rizatriptan Flas Qualigen:

• if you are already taking a 5-HT1B/1D agonist (sometimes called "triptans"), such as sumatriptan, naratriptan, or zolmitriptan.
• if you are taking a monoamine oxidase inhibitor (MAOI), such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline, or if it has been less than two weeks since you stopped taking an MAOI.
• if you are taking ergotamine-like medications, such as ergotamine or dihydroergotamine for migraine.
• if you are taking methysergide for migraine prevention.

The medications mentioned above, when taken with Rizatriptan Flas Qualigen, may increase the risk of side effects.

After taking Rizatriptan Flas Qualigen, you should wait at least 6 hours before taking ergotamine-like medications, such as ergotamine, dihydroergotamine, or methysergide.

After taking ergotamine-like medications, you should wait at least 24 hours before taking Rizatriptan Flas Qualigen.

Ask your doctor for instructions on how to take Rizatriptan Flas Qualigen and information about the risks

• if you are currently taking propranolol (see section 3 How to take Rizatriptan Flas Qualigen).
• if you are currently taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram, and fluoxetine or serotonin and norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine and duloxetine for depression.

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medication.

Taking Rizatriptan Flas Qualigen with food and drinks

Rizatriptan Flas Qualigen may take longer to work if taken after meals. Although it is best taken on an empty stomach, you can still take it even if you have eaten.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Available data on the safety of rizatriptan when used during the first three months of pregnancy do not indicate an increased risk of birth defects. It is unknown whether Rizatriptan Flas Qualigen is harmful to the fetus when taken by a pregnant woman after the first three months of pregnancy.

If you are breastfeeding, you may postpone breastfeeding for 12 hours after treatment to avoid exposing the baby.

Children and adolescents

Rizatriptan Flas Qualigen is not recommended for use in children under 18 years of age.

Use in patients over 65 years of age

There are no complete studies that evaluate the safety and efficacy of Rizatriptan Flas Qualigen in patients over 65 years of age.

Driving and using machines

When taking Rizatriptan Flas Qualigen, you may feel drowsy or dizzy. If this occurs, do not drive or use tools or machines.

Important information about some of the ingredients of Rizatriptan Flas Qualigen

This tablet contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

This medication contains 3.90 mg of aspartame in each tablet. Aspartame is a source of phenylalanine, which may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.

This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".

3. How to take Rizatriptan Flas Qualigen

Rizatriptan Flas Qualigen is used to treat migraine attacks. Take Rizatriptan Flas Qualigen as soon as possible after your migraine headache starts. Do not use it to prevent an attack.

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

The recommended dose is 10 mg.

If you are currently taking propranolol or have kidney or liver problems, you should use the 5 mg dose of Rizatriptan Flas Qualigen. You should wait at least 2 hours between taking propranolol and Rizatriptan Flas Qualigen, up to a maximum of 2 doses in a 24-hour period.

If your migraine comes back within 24 hours

In some patients, migraine symptoms may come back within 24 hours. If your migraine comes back, you can take an additional dose of Rizatriptan Flas Qualigen. You should always wait at least 2 hours between doses.

If after 2 hours you still have a migraine

If you do not respond to the first dose of Rizatriptan Flas Qualigen during an attack, you should not take a second dose of Rizatriptan Flas Qualigen for the treatment of the same attack. However, you may still respond to Rizatriptan Flas Qualigen during the next attack.

Do not take more than 2 doses of Rizatriptan Flas Qualigen in a 24-hour period (for example, do not take more than two 10 mg oral disintegrating tablets in a 24-hour period). You should always wait at least 2 hours between doses.

If your condition worsens, seek medical attention.

How to administer Rizatriptan Flas Qualigen

• Open the blister pack of the oral disintegrating tablet with dry hands.
• Place the oral disintegrating tablet on your tongue, where it will dissolve so that it can be swallowed with your saliva.
• The oral disintegrating tablet can be used in situations where liquids are not available or to avoid nausea and vomiting that may accompany taking tablets with liquids.

Rizatriptan is also available in tablets for taking with liquids.

If you take more Rizatriptan Flas Qualigen than you should

If you take more Rizatriptan Flas Qualigen than you should, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, telephone 91 5620420, indicating the medication and the amount taken. It is recommended to bring the packaging and package leaflet of the medication to the healthcare professional.

Signs of overdose may include dizziness, drowsiness, vomiting, fainting, and slow heart rate.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone gets them. The following side effects may occur with this medication.

In adult studies, the most frequently reported side effects were dizziness, drowsiness, and fatigue.

Frequent (affect 1 to 10 in every 100 patients):

• tingling sensation (paresthesia), headache, reduced skin sensitivity (hypoesthesia), decreased mental sharpness, insomnia.
• rapid or irregular heartbeat (palpitations).
• flushing (short-term redness of the face).
• throat discomfort.
• nausea, dry mouth, vomiting, diarrhea, indigestion (dyspepsia).
• heaviness in parts of the body, neck pain, numbness.
• abdominal or chest pain.

Uncommon (affect 1 to 10 in every 1,000 patients):

• unpleasant taste in the mouth.
• unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision, tremors, fainting (syncope).
• confusion, nervousness.
• high blood pressure (hypertension); thirst, hot flashes, sweating.
• skin rash, itching, and hives (urticaria); swelling of the face, lips, tongue, or throat that can cause difficulty breathing or swallowing (angioedema), difficulty breathing (dyspnea).
• stiffness in parts of the body, muscle weakness.
• changes in heart rhythm or frequency (arrhythmia); alterations in the electrocardiogram (a test that records the electrical activity of your heart), very rapid heart rate (tachycardia).
• facial pain; muscle pain.

Rare (affect 1 to 10 in every 10,000 patients):

• breathing difficulties.
• allergic reaction (hypersensitivity), sudden and potentially life-threatening allergic reaction (anaphylaxis).
• stroke (this usually occurs in patients with risk factors for heart or blood vessel disease, such as high blood pressure, diabetes, smoking, or using nicotine substitutes, family history of heart disease or stroke, being a male over 40 years old or a postmenopausal woman, and a specific problem with the way the heart beats (left bundle branch block)).
• slow heart rate (bradycardia).

Frequency not known (frequency cannot be estimated from available data):

• heart attack, spasms in the blood vessels of the heart (these usually occur in patients with risk factors for heart or blood vessel disease, such as high blood pressure, diabetes, smoking, or using nicotine substitutes, family history of heart disease or stroke, being a male over 40 years old or a postmenopausal woman, and a specific problem with the way the heart beats (left bundle branch block)).
• a syndrome called "serotonin syndrome" that can cause side effects such as coma, unstable blood pressure, extremely high fever, lack of muscle coordination, agitation, and hallucinations.
• severe skin peeling with or without fever (toxic epidermal necrolysis).
• seizures (convulsions/fits).
• contraction of blood vessels in the limbs, including cooling and numbness of hands and feet.
• contraction of blood vessels in the colon (large intestine), which can cause abdominal pain.

Tell your doctor immediately if you have symptoms of an allergic reaction, serotonin syndrome, heart attack, or stroke.

Also, tell your doctor if you experience any symptoms that indicate an allergic reaction (such as rash or itching) after taking Rizatriptan Flas Qualigen.

Reporting side effects:If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Rizatriptan Flas Qualigen

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the carton/outer packaging/foil/blister after "EXP". The expiration date is the last day of the month indicated.

Do not store above 30°C.

Medications should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and further information

Composition of Rizatriptan Flas Qualigen

• The active ingredient is rizatriptan. One oral disintegrating tablet contains 10 mg of rizatriptan, equivalent to 14.53 mg of rizatriptan benzoate.
• The other ingredients are: lactose monohydrate, microcrystalline cellulose (E460a), calcium silicate, crospovidone, aspartame (E951), peppermint flavor, colloidal anhydrous silica (E551), and magnesium stearate (E470b).

Appearance of the product and pack contents

The 10 mg oral disintegrating tablets are white, flat-faced, and round.

Rizatriptan Flas Qualigen 10 mg oral disintegrating tablets are available in packs of 2 or 6 tablets.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Neuraxpharm Spain, S.L.U.

Avenida Barcelona 69

08970 Sant Joan Despí

Barcelona, Spain

Manufacturer:

Neuraxpharm Pharmaceuticals, S.L.

Avenida Barcelona 69

08970 Sant Joan Despí (Barcelona)

Spain

Date of the last revision of this package leaflet:May 2024

Other sources of information

Detailed and up-to-date information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.